$NORD
Nordicus Partners Corp

2022 Q4 Form 10-Q Financial Statement

#000149315222031822 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $853.0K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $853.0K $47.00K $5.035M
YoY Change 2032.5% -68.03% 7197.1%
Operating Profit -$853.0K -$47.00K -$5.035M
YoY Change 2032.5% -68.03% 7197.1%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $2.000K
YoY Change
Pretax Income -$851.0K -$47.00K -$5.035M
YoY Change 2027.5% -68.03% 10612.77%
Income Tax
% Of Pretax Income
Net Earnings -$851.0K -$47.00K -$5.035M
YoY Change 2027.5% -68.03% 10612.77%
Net Earnings / Revenue
Basic Earnings Per Share -$0.15 -$0.01 -$0.89
Diluted Earnings Per Share -$0.15 -$8.273K -$886.2K
COMMON SHARES
Basic Shares Outstanding 5.681M shares 5.681M shares 5.681M shares
Diluted Shares Outstanding 5.681M shares 5.681M shares 5.681M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.000K $1.000K $186.0K
YoY Change -95.9% -66.67% 279.59%
Cash & Equivalents $5.000K $1.000K $186.0K
Short-Term Investments
Other Short-Term Assets $1.000K $9.000K $2.000K
YoY Change
Inventory
Prepaid Expenses $1.000K $9.000K $2.000K
Receivables
Other Receivables
Total Short-Term Assets $6.000K $10.00K $188.0K
YoY Change -95.08% 233.33% 283.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $6.000K $10.00K $188.0K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $6.000K $10.00K $188.0K
YoY Change -95.08% 233.33% 283.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $22.00K $7.000K
YoY Change -100.0% -80.87% -50.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $40.00K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.00K $28.00K $18.00K
YoY Change -32.43% -75.65% 28.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $50.00K $28.00K $18.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $50.00K $28.00K $18.00K
YoY Change -32.43% -75.65% 28.57%
SHAREHOLDERS EQUITY
Retained Earnings -$39.66M -$38.81M -$38.76M
YoY Change
Common Stock $6.000K $6.000K $6.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $30.00K $30.00K $30.00K
YoY Change
Treasury Stock Shares 1.534K shares 1.534K shares 1.534K shares
Shareholders Equity -$44.00K -$18.00K $170.0K
YoY Change
Total Liabilities & Shareholders Equity $6.000K $10.00K $188.0K
YoY Change -95.08% 233.33% 283.67%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$851.0K -$47.00K -$5.035M
YoY Change 2027.5% -68.03% 10612.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$36.00K -$44.00K -$60.00K
YoY Change -55.56% -4.35% -24.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.00K -141.0K
YoY Change -80.0%
NET CHANGE
Cash From Operating Activities -36.00K -44.00K -$60.00K
Cash From Investing Activities
Cash From Financing Activities 40.00K -141.0K
Net Change In Cash 4.000K -185.0K -$60.00K
YoY Change -96.64% 302.17% -24.05%
FREE CASH FLOW
Cash From Operating Activities -$36.00K -$44.00K -$60.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001011060
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 ASNB Transaction Fee
TransactionFee
usd
CY2021Q3 ASNB Transaction Fee
TransactionFee
usd
ASNB Transaction Fee
TransactionFee
usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-28034
dei Entity Registrant Name
EntityRegistrantName
EKIMAS CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3186647
dei Entity Address Address Line1
EntityAddressAddressLine1
3651 Lindell Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite D565
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89103
dei City Area Code
CityAreaCode
(424)
dei Local Phone Number
LocalPhoneNumber
256-8560
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5681248 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
246000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9000 usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
10000 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
250000 usd
CY2022Q3 us-gaap Assets
Assets
10000 usd
CY2022Q1 us-gaap Assets
Assets
250000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
22000 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43000 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
6000 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
12000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
28000 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
55000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
28000 usd
CY2022Q1 us-gaap Liabilities
Liabilities
55000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5682782 shares
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
47000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
147000 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5682782 shares
us-gaap Operating Expenses
OperatingExpenses
5082000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10000 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250000 usd
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5681248 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5681248 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38813000 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33944000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38807000 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33725000 usd
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1534 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1534 shares
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
30000 usd
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
30000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-18000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
195000 usd
us-gaap Operating Expenses
OperatingExpenses
216000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-47000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-147000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5082000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-216000 usd
ASNB Transaction Fee
TransactionFee
22000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-147000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5082000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-194000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-47000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-147000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5082000 usd
us-gaap Net Income Loss
NetIncomeLoss
-194000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5681248 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
566773 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5681248 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
566773 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
82000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
35000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-147000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-112000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
195000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5010000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5035000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
170000 usd
CY2022Q3 ASNB Adjustment To Additional Paid In Capital Cash Distribution To Stockholders
AdjustmentToAdditionalPaidInCapitalCashDistributionToStockholders
-141000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-47000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-18000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5082000 usd
us-gaap Net Income Loss
NetIncomeLoss
-194000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5010000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
69000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-6000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-104000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-125000 usd
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
141000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-141000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-245000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-125000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
246000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
128000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-47000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-147000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5082000 usd
us-gaap Net Income Loss
NetIncomeLoss
-194000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-104000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-125000 usd
CY2022Q3 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
141000 usd
CY2022Q3 us-gaap Share Price
SharePrice
0.25
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
ASNB Preferred Stock Issued And Redeemed Shares
PreferredStockIssuedAndRedeemedShares
500000 shares
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5010000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5010000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1500000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q2 us-gaap Cash
Cash
22000 usd
us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
0 usd
us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.25
CY2022Q3 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
141000 usd
CY2022Q3 us-gaap Share Price
SharePrice
0.25

Files In Submission

Name View Source Status
0001493152-22-031822-index-headers.html Edgar Link pending
0001493152-22-031822-index.html Edgar Link pending
0001493152-22-031822.txt Edgar Link pending
0001493152-22-031822-xbrl.zip Edgar Link pending
asnb-20220930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
asnb-20220930_cal.xml Edgar Link unprocessable
asnb-20220930_lab.xml Edgar Link unprocessable
asnb-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
asnb-20220930_def.xml Edgar Link unprocessable